Order Article Reprints

Farrell AG, Dadonaite B, Greaney AJ, Eguia R, Loes AN, Franko NM, Logue J, Carreño JM, Abbad A, Chu HY, et al. Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2. Viruses. 2022; 14(9):2061. https://doi.org/10.3390/v14092061

Farrell, Ariana Ghez, Bernadeta Dadonaite, Allison J. Greaney, Rachel Eguia, Andrea N. Loes, Nicholas M. Franko, Jennifer Logue, Juan Manuel Carreño, Anass Abbad, Helen Y. Chu, and et al. 2022. "Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2" Viruses 14, no. 9: 2061. https://doi.org/10.3390/v14092061

Farrell, A. G., Dadonaite, B., Greaney, A. J., Eguia, R., Loes, A. N., Franko, N. M., Logue, J., Carreño, J. M., Abbad, A., Chu, H. Y., Matreyek, K. A., & Bloom, J. D. (2022). Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2. Viruses, 14(9), 2061. https://doi.org/10.3390/v14092061